Johnson CS - Search Results

1

Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel.

Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, Capozzoli MJ, Egorin MJ, Johnson CS, Trump DL. Muindi JR, et al. Among authors: johnson cs. Clin Pharmacol Ther. 2002 Dec;72(6):648-59. doi: 10.1067/mcp.2002.129305. Clin Pharmacol Ther. 2002. PMID: 12496746 Clinical Trial.

2

Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model.

Ahmed S, Johnson CS, Rueger RM, Trump DL. Ahmed S, et al. Among authors: johnson cs. J Urol. 2002 Aug;168(2):756-61. J Urol. 2002. PMID: 12131364

3

Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate.

Matin K, Egorin MJ, Ballesteros MF, Smith DC, Lembersky B, Day RS, Johnson CS, Trump DL. Matin K, et al. Among authors: johnson cs. Cancer Chemother Pharmacol. 2002 Sep;50(3):179-85. doi: 10.1007/s00280-002-0484-9. Epub 2002 Jul 19. Cancer Chemother Pharmacol. 2002. PMID: 12203099 Clinical Trial.

4

Vitamin D receptor: a potential target for intervention.

Johnson CS, Hershberger PA, Bernardi RJ, Mcguire TF, Trump DL. Johnson CS, et al. Urology. 2002 Sep;60(3 Suppl 1):123-30; discussion 130-1. doi: 10.1016/s0090-4295(02)01591-1. Urology. 2002. PMID: 12231068 Review.

5

Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression.

Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, Trump DL, Johnson CS. Hershberger PA, et al. Among authors: johnson cs. Mol Cancer Ther. 2002 Aug;1(10):821-9. Mol Cancer Ther. 2002. PMID: 12492115

6

A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patients.

Muindi JR, Wilson JW, Peng Y, Capozolli MJ, Johnson CS, Trump DL. Muindi JR, et al. Among authors: johnson cs. J Clin Pharmacol. 2003 Aug;43(8):894-900. doi: 10.1177/0091270003255925. J Clin Pharmacol. 2003. PMID: 12953346 Clinical Trial.

7

Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses.

Muindi JR, Modzelewski RA, Peng Y, Trump DL, Johnson CS. Muindi JR, et al. Among authors: johnson cs. Oncology. 2004;66(1):62-6. doi: 10.1159/000076336. Oncology. 2004. PMID: 15031600

8

Pharmacokinetics of liquid calcitriol formulation in advanced solid tumor patients: comparison with caplet formulation.

Muindi JR, Potter DM, Peng Y, Johnson CS, Trump DL. Muindi JR, et al. Among authors: johnson cs. Cancer Chemother Pharmacol. 2005 Nov;56(5):492-6. doi: 10.1007/s00280-005-1015-2. Epub 2005 May 26. Cancer Chemother Pharmacol. 2005. PMID: 15918041 Clinical Trial.

9

Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.

Muindi JR, Peng Y, Wilson JW, Johnson CS, Branch RA, Trump DL. Muindi JR, et al. Among authors: johnson cs. Cancer Chemother Pharmacol. 2007 Jan;59(1):97-104. doi: 10.1007/s00280-006-0247-0. Epub 2006 May 6. Cancer Chemother Pharmacol. 2007. PMID: 16680461 Clinical Trial.

10

A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.

Muindi JR, Johnson CS, Trump DL, Christy R, Engler KL, Fakih MG. Muindi JR, et al. Among authors: johnson cs. Cancer Chemother Pharmacol. 2009 Dec;65(1):33-40. doi: 10.1007/s00280-009-1000-2. Epub 2009 Apr 26. Cancer Chemother Pharmacol. 2009. PMID: 19396601 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters